RT @ericdeinmd: #EULAR2022 LB0005 Orelabrutinib- BTKi- for SLE, PIb/IIa âï¸Improved SRI-4 and SLEDAI-2K vs PBO, dose
Tweet Content
#EULAR2022 LB0005
Orelabrutinib- BTKi- for SLE, PIb/IIa
⭐️Improved SRI-4 and SLEDAI-2K vs PBO, dose response for SRI-4
⭐️Improved proteinuria
@Rheumnow https://t.co/bmREhmL7sq
Show on Archive Page
On
Display in Search Results
On
PDQ
Off